Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Extracellular matrix in skeletal muscle injury and atrophy: mechanisms and therapeutic implications

Ge X., Jin Y., He J., Jia Z., Liu Y., Xu Y.

Narrative Review on Immune Modulation, published in J Orthop Translat (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Orthop Translat (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40485851
PMCID
PMC12145571
DOI
10.1016/j.jot.2025.03.004
Citations
18

Abstract (original English)

Extracellular matrix (ECM) is an intricate, dynamic network that is essential for structural and biochemical support of skeletal muscle cells. Upon skeletal muscle injury, ECM undergoes rapid remodeling to clear damaged tissue and provides a scaffold to support muscle regeneration. Disruptions in the structure and composition of ECM lead to fibrosis and impaired muscle function, consequently hindering the regenerative capability of skeletal muscle following acute injury. Besides, dysregulation of ECM can also affect muscle mass and cross-sectional area, contributing to the onset of muscle atrophy. Thus, understanding the physiological and mechanical roles of ECM in skeletal muscle injury and atrophy is crucial for developing strategies to treat muscle-related diseases. This review focuses on the complex interactions between the ECM and skeletal muscle, aiming to summarize the regulatory function and mechanism of ECM in muscle development, injury repair, and atrophy. Additionally, it covers recent advances in the treatment of skeletal muscle diseases via the utilization or modulation of ECM components. We will discuss the potential benefits of ECM-based therapies and the current challenges in this area, including producing standardized ECM, minimizing graft-versus-host disease (GVHD), and ensuring that scaffolds have the appropriate biological function. In sum, this comprehensiv

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research